Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey's Max Jackson promoted

Sudler & Hennessey has announced that Max Jackson has been promoted to CEO of both its EMEA and APAC regions

Sudler & Hennessey has announced that Max Jackson has been promoted to CEO of both its Europe/Middle East/Africa (EMEA) and Asia Pacific (APAC) regions.

Formerly responsible for leading the company's EMEA region, Jackson will lead over 30 dedicated healthcare offices across three continents. He will also look to expand Sudler & Hennessey's offerings to meet the evolving needs of healthcare clients.

"The APAC region probably has the largest growth potential in healthcare, as well as presenting a number of significant challenges, both geographical, socio-economic, and technological. We are looking forward to continuing our leadership in this region, and to a rich exchange of ideas between the established and developing markets," said Jackson.

Jackson has a strong interest in developing new business models in the digital/new media arena, and in particular, in emerging markets. He has worked in healthcare communications for 19 years, both on the client-side and in various agencies. The last eight years of his career have been spent leading large healthcare communications networks globally and he has extensive global marketing experience.

Jed Beitler, chairman and CEO of Sudler & Hennessey worldwide said: "Max has proven leadership skills, and has demonstrated very quickly that he understands how to navigate through the challenging healthcare marketplace, and help clients find the solutions necessary to maximise their brands potential."

17th February 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics